[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fjQXci7gqXWPSOY_lAj0bkrT2PRMNSCwrznHskLIhbIc":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":33,"phaseBuckets":49,"rows":56},"Universiteit Antwerpen",[4],126,false,22,7,224911,4,104,[14,17,20,22,24,26,28,30],{"name":15,"count":16},"Stroke",11,{"name":18,"count":19},"Human Papilloma Virus",5,{"name":21,"count":19},"HPV-Related Cervical Carcinoma",{"name":23,"count":19},"Overactive Bladder",{"name":25,"count":19},"Cervical Cancer",{"name":27,"count":11},"Cervical Intraepithelial Neoplasia",{"name":29,"count":11},"Epilepsy",{"name":31,"count":32},"Gait, Hemiplegic",3,[34,39,44],{"nctId":35,"briefTitle":36,"date":37,"intervention":38},"NCT05644301","INflammation-based Stratification for Immune-Targeted Augmentation in Major Depressive Disorder","2026-09","Celecoxib",{"nctId":40,"briefTitle":41,"date":42,"intervention":43},"NCT06296082","Comparative Study of the Effects of Dry Needling and Botulinum Toxin Type A as a Treatment for Lower Limb Post-stroke Spasticity","2026-12-30","Botulinum toxin type A",{"nctId":45,"briefTitle":46,"date":47,"intervention":48},"NCT07407569","Developing a First-void Urine-based Infection Model to Study HPV-specific Antibody-virion Interaction Before and After HPV Vaccination","2029-01-01","Gardasil 9",[50,51,52,53,54,55],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[57,83,101,122,143,171,196,228,246,264,282,300,318,345,363,381,399,424,451,469,487,515,533,551,569,596,622,640,665,691,729,754,779,804,822,847,871],{"intervention":38,"totalTrials":58,"cells":59},1,{"EARLY_PHASE1":60,"PHASE1":63,"PHASE2":65,"PHASE3":67,"PHASE4":79,"NA":81},{"trials":61,"activeCount":62},[],0,{"trials":64,"activeCount":62},[],{"trials":66,"activeCount":62},[],{"trials":68,"activeCount":58,"soonestReadout":37},[69],{"nctId":35,"briefTitle":36,"status":70,"phases":71,"primaryCompletion":37,"completion":37,"start":72,"enrollment":73,"conditions":74,"interventions":77},"RECRUITING",[53],"2023-09-21",240,[75,76],"Major Depressive Disorder","Inflammation",[38,78],"Minocyclin",{"trials":80,"activeCount":62},[],{"trials":82,"activeCount":62},[],{"intervention":78,"totalTrials":58,"cells":84},{"EARLY_PHASE1":85,"PHASE1":87,"PHASE2":89,"PHASE3":91,"PHASE4":97,"NA":99},{"trials":86,"activeCount":62},[],{"trials":88,"activeCount":62},[],{"trials":90,"activeCount":62},[],{"trials":92,"activeCount":58,"soonestReadout":37},[93],{"nctId":35,"briefTitle":36,"status":70,"phases":94,"primaryCompletion":37,"completion":37,"start":72,"enrollment":73,"conditions":95,"interventions":96},[53],[75,76],[38,78],{"trials":98,"activeCount":62},[],{"trials":100,"activeCount":62},[],{"intervention":43,"totalTrials":58,"cells":102},{"EARLY_PHASE1":103,"PHASE1":105,"PHASE2":107,"PHASE3":109,"PHASE4":118,"NA":120},{"trials":104,"activeCount":62},[],{"trials":106,"activeCount":62},[],{"trials":108,"activeCount":62},[],{"trials":110,"activeCount":58,"soonestReadout":42},[111],{"nctId":40,"briefTitle":41,"status":70,"phases":112,"primaryCompletion":42,"completion":113,"start":114,"enrollment":115,"conditions":116,"interventions":117},[52,53],"2027-03-29","2024-09-01",90,[15],[43],{"trials":119,"activeCount":62},[],{"trials":121,"activeCount":62},[],{"intervention":48,"totalTrials":58,"cells":123},{"EARLY_PHASE1":124,"PHASE1":126,"PHASE2":128,"PHASE3":137,"PHASE4":139,"NA":141},{"trials":125,"activeCount":62},[],{"trials":127,"activeCount":62},[],{"trials":129,"activeCount":58,"soonestReadout":47},[130],{"nctId":45,"briefTitle":46,"status":70,"phases":131,"primaryCompletion":47,"completion":47,"start":132,"enrollment":133,"conditions":134,"interventions":136},[52],"2026-03-25",50,[135],"Human Papilloma Virus Infection Type 16",[48],{"trials":138,"activeCount":62},[],{"trials":140,"activeCount":62},[],{"trials":142,"activeCount":62},[],{"intervention":144,"totalTrials":58,"cells":145},"Pertussis vaccine",{"EARLY_PHASE1":146,"PHASE1":148,"PHASE2":150,"PHASE3":152,"PHASE4":154,"NA":169},{"trials":147,"activeCount":62},[],{"trials":149,"activeCount":62},[],{"trials":151,"activeCount":62},[],{"trials":153,"activeCount":62},[],{"trials":155,"activeCount":62},[156],{"nctId":157,"briefTitle":158,"status":159,"phases":160,"primaryCompletion":161,"completion":162,"start":163,"enrollment":164,"conditions":165,"interventions":168},"NCT01698346","Pertussis (Tdap) Vaccination in Pregnancy","COMPLETED",[54],"2015-12","2016-12","2012-02",99,[166,167],"Pertussis","Pregnancy",[144],{"trials":170,"activeCount":62},[],{"intervention":172,"totalTrials":58,"cells":173},"ivermectin",{"EARLY_PHASE1":174,"PHASE1":176,"PHASE2":178,"PHASE3":180,"PHASE4":182,"NA":194},{"trials":175,"activeCount":62},[],{"trials":177,"activeCount":62},[],{"trials":179,"activeCount":62},[],{"trials":181,"activeCount":62},[],{"trials":183,"activeCount":62},[184],{"nctId":185,"briefTitle":186,"status":159,"phases":187,"primaryCompletion":188,"completion":189,"start":190,"enrollment":191,"conditions":192,"interventions":193},"NCT03852303","Ivermectin Treatment of Persons With Onchocerciasis-associated Epilepsy",[54],"2019-03-31","2019-07-01","2017-10-01",197,[29],[172],{"trials":195,"activeCount":62},[],{"intervention":197,"totalTrials":58,"cells":198},"BNT162b2 30µg",{"EARLY_PHASE1":199,"PHASE1":201,"PHASE2":203,"PHASE3":205,"PHASE4":207,"NA":226},{"trials":200,"activeCount":62},[],{"trials":202,"activeCount":62},[],{"trials":204,"activeCount":62},[],{"trials":206,"activeCount":62},[],{"trials":208,"activeCount":62},[209],{"nctId":210,"briefTitle":211,"status":159,"phases":212,"primaryCompletion":213,"completion":214,"start":215,"enrollment":216,"conditions":217,"interventions":220},"NCT06189040","Immunogenicity After COVID-19 Vaccines in Adapted Schedules",[54],"2021-11-03","2022-07-08","2021-05-26",580,[218,219],"Coronavirus Disease 2019","COVID-19",[197,221,222,223,224,225],"BNT162b2 20µg","BNT162b2 6µg","mRNA-1273 100µg","mRNA-1273 50µg","ChAdOx1-S [Recombinant]",{"trials":227,"activeCount":62},[],{"intervention":221,"totalTrials":58,"cells":229},{"EARLY_PHASE1":230,"PHASE1":232,"PHASE2":234,"PHASE3":236,"PHASE4":238,"NA":244},{"trials":231,"activeCount":62},[],{"trials":233,"activeCount":62},[],{"trials":235,"activeCount":62},[],{"trials":237,"activeCount":62},[],{"trials":239,"activeCount":62},[240],{"nctId":210,"briefTitle":211,"status":159,"phases":241,"primaryCompletion":213,"completion":214,"start":215,"enrollment":216,"conditions":242,"interventions":243},[54],[218,219],[197,221,222,223,224,225],{"trials":245,"activeCount":62},[],{"intervention":222,"totalTrials":58,"cells":247},{"EARLY_PHASE1":248,"PHASE1":250,"PHASE2":252,"PHASE3":254,"PHASE4":256,"NA":262},{"trials":249,"activeCount":62},[],{"trials":251,"activeCount":62},[],{"trials":253,"activeCount":62},[],{"trials":255,"activeCount":62},[],{"trials":257,"activeCount":62},[258],{"nctId":210,"briefTitle":211,"status":159,"phases":259,"primaryCompletion":213,"completion":214,"start":215,"enrollment":216,"conditions":260,"interventions":261},[54],[218,219],[197,221,222,223,224,225],{"trials":263,"activeCount":62},[],{"intervention":223,"totalTrials":58,"cells":265},{"EARLY_PHASE1":266,"PHASE1":268,"PHASE2":270,"PHASE3":272,"PHASE4":274,"NA":280},{"trials":267,"activeCount":62},[],{"trials":269,"activeCount":62},[],{"trials":271,"activeCount":62},[],{"trials":273,"activeCount":62},[],{"trials":275,"activeCount":62},[276],{"nctId":210,"briefTitle":211,"status":159,"phases":277,"primaryCompletion":213,"completion":214,"start":215,"enrollment":216,"conditions":278,"interventions":279},[54],[218,219],[197,221,222,223,224,225],{"trials":281,"activeCount":62},[],{"intervention":224,"totalTrials":58,"cells":283},{"EARLY_PHASE1":284,"PHASE1":286,"PHASE2":288,"PHASE3":290,"PHASE4":292,"NA":298},{"trials":285,"activeCount":62},[],{"trials":287,"activeCount":62},[],{"trials":289,"activeCount":62},[],{"trials":291,"activeCount":62},[],{"trials":293,"activeCount":62},[294],{"nctId":210,"briefTitle":211,"status":159,"phases":295,"primaryCompletion":213,"completion":214,"start":215,"enrollment":216,"conditions":296,"interventions":297},[54],[218,219],[197,221,222,223,224,225],{"trials":299,"activeCount":62},[],{"intervention":225,"totalTrials":58,"cells":301},{"EARLY_PHASE1":302,"PHASE1":304,"PHASE2":306,"PHASE3":308,"PHASE4":310,"NA":316},{"trials":303,"activeCount":62},[],{"trials":305,"activeCount":62},[],{"trials":307,"activeCount":62},[],{"trials":309,"activeCount":62},[],{"trials":311,"activeCount":62},[312],{"nctId":210,"briefTitle":211,"status":159,"phases":313,"primaryCompletion":213,"completion":214,"start":215,"enrollment":216,"conditions":314,"interventions":315},[54],[218,219],[197,221,222,223,224,225],{"trials":317,"activeCount":62},[],{"intervention":319,"totalTrials":58,"cells":320},"Boostrix",{"EARLY_PHASE1":321,"PHASE1":323,"PHASE2":325,"PHASE3":327,"PHASE4":329,"NA":343},{"trials":322,"activeCount":62},[],{"trials":324,"activeCount":62},[],{"trials":326,"activeCount":62},[],{"trials":328,"activeCount":62},[],{"trials":330,"activeCount":62},[331],{"nctId":332,"briefTitle":333,"status":159,"phases":334,"primaryCompletion":335,"completion":335,"start":336,"enrollment":337,"conditions":338,"interventions":339},"NCT02408926","Vaccine Responses in Infants After Acellular Pertussis Vaccination During Pregnancy in Thailand",[54],"2018-08","2015-04",370,[166],[319,340,341,342],"Infanrix hexa","Quinvaxem","OPV",{"trials":344,"activeCount":62},[],{"intervention":340,"totalTrials":58,"cells":346},{"EARLY_PHASE1":347,"PHASE1":349,"PHASE2":351,"PHASE3":353,"PHASE4":355,"NA":361},{"trials":348,"activeCount":62},[],{"trials":350,"activeCount":62},[],{"trials":352,"activeCount":62},[],{"trials":354,"activeCount":62},[],{"trials":356,"activeCount":62},[357],{"nctId":332,"briefTitle":333,"status":159,"phases":358,"primaryCompletion":335,"completion":335,"start":336,"enrollment":337,"conditions":359,"interventions":360},[54],[166],[319,340,341,342],{"trials":362,"activeCount":62},[],{"intervention":341,"totalTrials":58,"cells":364},{"EARLY_PHASE1":365,"PHASE1":367,"PHASE2":369,"PHASE3":371,"PHASE4":373,"NA":379},{"trials":366,"activeCount":62},[],{"trials":368,"activeCount":62},[],{"trials":370,"activeCount":62},[],{"trials":372,"activeCount":62},[],{"trials":374,"activeCount":62},[375],{"nctId":332,"briefTitle":333,"status":159,"phases":376,"primaryCompletion":335,"completion":335,"start":336,"enrollment":337,"conditions":377,"interventions":378},[54],[166],[319,340,341,342],{"trials":380,"activeCount":62},[],{"intervention":342,"totalTrials":58,"cells":382},{"EARLY_PHASE1":383,"PHASE1":385,"PHASE2":387,"PHASE3":389,"PHASE4":391,"NA":397},{"trials":384,"activeCount":62},[],{"trials":386,"activeCount":62},[],{"trials":388,"activeCount":62},[],{"trials":390,"activeCount":62},[],{"trials":392,"activeCount":62},[393],{"nctId":332,"briefTitle":333,"status":159,"phases":394,"primaryCompletion":335,"completion":335,"start":336,"enrollment":337,"conditions":395,"interventions":396},[54],[166],[319,340,341,342],{"trials":398,"activeCount":62},[],{"intervention":400,"totalTrials":58,"cells":401},"Lactobacillus casei Shirota",{"EARLY_PHASE1":402,"PHASE1":404,"PHASE2":406,"PHASE3":408,"PHASE4":410,"NA":422},{"trials":403,"activeCount":62},[],{"trials":405,"activeCount":62},[],{"trials":407,"activeCount":62},[],{"trials":409,"activeCount":62},[],{"trials":411,"activeCount":62},[412],{"nctId":413,"briefTitle":414,"status":159,"phases":415,"primaryCompletion":416,"completion":416,"start":417,"enrollment":418,"conditions":419,"interventions":421},"NCT00849277","Study of the Effect of Probiotics on Respiratory Morbidity After Influenza Vaccination of Elderly in Nursing Homes",[54],"2008-04","2006-10",737,[420],"Respiratory Tract Infections",[400],{"trials":423,"activeCount":62},[],{"intervention":425,"totalTrials":58,"cells":426},"Artemether\u002FLumefantrine",{"EARLY_PHASE1":427,"PHASE1":429,"PHASE2":431,"PHASE3":433,"PHASE4":447,"NA":449},{"trials":428,"activeCount":62},[],{"trials":430,"activeCount":62},[],{"trials":432,"activeCount":62},[],{"trials":434,"activeCount":62},[435],{"nctId":436,"briefTitle":437,"status":159,"phases":438,"primaryCompletion":439,"completion":439,"start":440,"enrollment":441,"conditions":442,"interventions":444},"NCT01374581","Impact of Artemisinin-based Combination Therapy and Quinine on Treatment Failure and Resistance in Uncomplicated Malaria",[53],"2014-06","2012-05",2117,[443],"Malaria",[425,445,446],"Artesunate\u002FAmodiaquine","Quinine + Clindamycin",{"trials":448,"activeCount":62},[],{"trials":450,"activeCount":62},[],{"intervention":445,"totalTrials":58,"cells":452},{"EARLY_PHASE1":453,"PHASE1":455,"PHASE2":457,"PHASE3":459,"PHASE4":465,"NA":467},{"trials":454,"activeCount":62},[],{"trials":456,"activeCount":62},[],{"trials":458,"activeCount":62},[],{"trials":460,"activeCount":62},[461],{"nctId":436,"briefTitle":437,"status":159,"phases":462,"primaryCompletion":439,"completion":439,"start":440,"enrollment":441,"conditions":463,"interventions":464},[53],[443],[425,445,446],{"trials":466,"activeCount":62},[],{"trials":468,"activeCount":62},[],{"intervention":446,"totalTrials":58,"cells":470},{"EARLY_PHASE1":471,"PHASE1":473,"PHASE2":475,"PHASE3":477,"PHASE4":483,"NA":485},{"trials":472,"activeCount":62},[],{"trials":474,"activeCount":62},[],{"trials":476,"activeCount":62},[],{"trials":478,"activeCount":62},[479],{"nctId":436,"briefTitle":437,"status":159,"phases":480,"primaryCompletion":439,"completion":439,"start":440,"enrollment":441,"conditions":481,"interventions":482},[53],[443],[425,445,446],{"trials":484,"activeCount":62},[],{"trials":486,"activeCount":62},[],{"intervention":488,"totalTrials":58,"cells":489},"Sulfadoxine-pyrimethamine",{"EARLY_PHASE1":490,"PHASE1":492,"PHASE2":494,"PHASE3":496,"PHASE4":511,"NA":513},{"trials":491,"activeCount":62},[],{"trials":493,"activeCount":62},[],{"trials":495,"activeCount":62},[],{"trials":497,"activeCount":62},[498],{"nctId":499,"briefTitle":500,"status":159,"phases":501,"primaryCompletion":502,"completion":502,"start":503,"enrollment":504,"conditions":505,"interventions":507},"NCT01722539","Impact IPT With Sulfadoxine-pyrimethamine or Sulfadoxine-pyrimethamine Plus Piperaquine in Schoolchildren",[53],"2013-11","2012-11",616,[506],"Healthy",[488,508,509,510],"Piperaquine","Albendazole","Praziquantel",{"trials":512,"activeCount":62},[],{"trials":514,"activeCount":62},[],{"intervention":508,"totalTrials":58,"cells":516},{"EARLY_PHASE1":517,"PHASE1":519,"PHASE2":521,"PHASE3":523,"PHASE4":529,"NA":531},{"trials":518,"activeCount":62},[],{"trials":520,"activeCount":62},[],{"trials":522,"activeCount":62},[],{"trials":524,"activeCount":62},[525],{"nctId":499,"briefTitle":500,"status":159,"phases":526,"primaryCompletion":502,"completion":502,"start":503,"enrollment":504,"conditions":527,"interventions":528},[53],[506],[488,508,509,510],{"trials":530,"activeCount":62},[],{"trials":532,"activeCount":62},[],{"intervention":509,"totalTrials":58,"cells":534},{"EARLY_PHASE1":535,"PHASE1":537,"PHASE2":539,"PHASE3":541,"PHASE4":547,"NA":549},{"trials":536,"activeCount":62},[],{"trials":538,"activeCount":62},[],{"trials":540,"activeCount":62},[],{"trials":542,"activeCount":62},[543],{"nctId":499,"briefTitle":500,"status":159,"phases":544,"primaryCompletion":502,"completion":502,"start":503,"enrollment":504,"conditions":545,"interventions":546},[53],[506],[488,508,509,510],{"trials":548,"activeCount":62},[],{"trials":550,"activeCount":62},[],{"intervention":510,"totalTrials":58,"cells":552},{"EARLY_PHASE1":553,"PHASE1":555,"PHASE2":557,"PHASE3":559,"PHASE4":565,"NA":567},{"trials":554,"activeCount":62},[],{"trials":556,"activeCount":62},[],{"trials":558,"activeCount":62},[],{"trials":560,"activeCount":62},[561],{"nctId":499,"briefTitle":500,"status":159,"phases":562,"primaryCompletion":502,"completion":502,"start":503,"enrollment":504,"conditions":563,"interventions":564},[53],[506],[488,508,509,510],{"trials":566,"activeCount":62},[],{"trials":568,"activeCount":62},[],{"intervention":570,"totalTrials":58,"cells":571},"systemic chemotherapy LV5FU2",{"EARLY_PHASE1":572,"PHASE1":574,"PHASE2":576,"PHASE3":578,"PHASE4":592,"NA":594},{"trials":573,"activeCount":62},[],{"trials":575,"activeCount":62},[],{"trials":577,"activeCount":62},[],{"trials":579,"activeCount":62},[580],{"nctId":581,"briefTitle":582,"status":583,"phases":584,"primaryCompletion":585,"completion":586,"start":587,"enrollment":588,"conditions":589,"interventions":591},"NCT01895257","Comparing HAI-90Y (SIR-spheres)+Chemotx LV5FU2 Versus Chemotx LV5FU2 Alone to Treat Colorectal Cancer","UNKNOWN",[53],"2017-12","2018-12","2013-08",162,[590],"Colorectal Cancer",[570],{"trials":593,"activeCount":62},[],{"trials":595,"activeCount":62},[],{"intervention":597,"totalTrials":58,"cells":598},"AV2-SA2",{"EARLY_PHASE1":599,"PHASE1":601,"PHASE2":603,"PHASE3":605,"PHASE4":618,"NA":620},{"trials":600,"activeCount":62},[],{"trials":602,"activeCount":62},[],{"trials":604,"activeCount":62},[],{"trials":606,"activeCount":62},[607],{"nctId":608,"briefTitle":609,"status":159,"phases":610,"primaryCompletion":611,"completion":611,"start":612,"enrollment":613,"conditions":614,"interventions":616},"NCT05862441","A Study to Assess the Efficacy of Omnivirol-Salicylic Acid Combination Therapy for Cutaneous Warts With Emphasis on Persistent Warts",[52,53],"2019-12-31","2018-01-01",260,[615],"Cutaneous Warts",[597,617],"SA",{"trials":619,"activeCount":62},[],{"trials":621,"activeCount":62},[],{"intervention":617,"totalTrials":58,"cells":623},{"EARLY_PHASE1":624,"PHASE1":626,"PHASE2":628,"PHASE3":630,"PHASE4":636,"NA":638},{"trials":625,"activeCount":62},[],{"trials":627,"activeCount":62},[],{"trials":629,"activeCount":62},[],{"trials":631,"activeCount":62},[632],{"nctId":608,"briefTitle":609,"status":159,"phases":633,"primaryCompletion":611,"completion":611,"start":612,"enrollment":613,"conditions":634,"interventions":635},[52,53],[615],[597,617],{"trials":637,"activeCount":62},[],{"trials":639,"activeCount":62},[],{"intervention":641,"totalTrials":58,"cells":642},"Metformin Hydrochloride",{"EARLY_PHASE1":643,"PHASE1":645,"PHASE2":647,"PHASE3":649,"PHASE4":661,"NA":663},{"trials":644,"activeCount":62},[],{"trials":646,"activeCount":62},[],{"trials":648,"activeCount":62},[],{"trials":650,"activeCount":62},[651],{"nctId":652,"briefTitle":653,"status":583,"phases":654,"primaryCompletion":655,"completion":655,"start":656,"enrollment":657,"conditions":658,"interventions":660},"NCT03831464","Metformin as RenoProtector of Progressive Kidney Disease",[53],"2024-12-31","2019-11-05",290,[659],"Chronic Kidney Diseases",[641],{"trials":662,"activeCount":62},[],{"trials":664,"activeCount":62},[],{"intervention":666,"totalTrials":58,"cells":667},"Ad26.ZEBOV vaccine",{"EARLY_PHASE1":668,"PHASE1":670,"PHASE2":672,"PHASE3":685,"PHASE4":687,"NA":689},{"trials":669,"activeCount":62},[],{"trials":671,"activeCount":62},[],{"trials":673,"activeCount":62},[674],{"nctId":675,"briefTitle":676,"status":159,"phases":677,"primaryCompletion":678,"completion":679,"start":680,"enrollment":681,"conditions":682,"interventions":684},"NCT04186000","Study to Evaluate the Immunogenicity and Safety of a Heterologous Vaccine Regimen Against Ebola",[52],"2020-04-25","2022-10-12","2019-12-18",699,[683],"Ebola Virus Disease",[666],{"trials":686,"activeCount":62},[],{"trials":688,"activeCount":62},[],{"trials":690,"activeCount":62},[],{"intervention":692,"totalTrials":693,"cells":694},"Bi-annual CDTI",2,{"EARLY_PHASE1":695,"PHASE1":697,"PHASE2":699,"PHASE3":701,"PHASE4":703,"NA":705},{"trials":696,"activeCount":62},[],{"trials":698,"activeCount":62},[],{"trials":700,"activeCount":62},[],{"trials":702,"activeCount":62},[],{"trials":704,"activeCount":62},[],{"trials":706,"activeCount":62},[707,718],{"nctId":708,"briefTitle":709,"status":159,"phases":710,"primaryCompletion":711,"completion":712,"start":713,"enrollment":714,"conditions":715,"interventions":717},"NCT05749653","Impact of a Bi-annual CDTI on the Incidence of Epilepsy in an Onchocerciasis-endemic Area",[55],"2021-03-01","2022-02-01","2017-03-01",6500,[716,29],"Onchocerciasis",[692],{"nctId":719,"briefTitle":720,"status":159,"phases":721,"primaryCompletion":722,"completion":723,"start":724,"enrollment":725,"conditions":726,"interventions":727},"NCT05750043","Effect of Onchocerciasis Elimination Measures on the Incidence of Epilepsy in Maridi, South Sudan",[],"2023-01-31","2023-02-19","2018-03-01",17000,[716,29],[728],"bi-annual CDTI",{"intervention":730,"totalTrials":58,"cells":731},"Lithium",{"EARLY_PHASE1":732,"PHASE1":734,"PHASE2":736,"PHASE3":738,"PHASE4":740,"NA":742},{"trials":733,"activeCount":62},[],{"trials":735,"activeCount":62},[],{"trials":737,"activeCount":62},[],{"trials":739,"activeCount":62},[],{"trials":741,"activeCount":62},[],{"trials":743,"activeCount":62},[744],{"nctId":745,"briefTitle":746,"status":159,"phases":747,"primaryCompletion":748,"completion":655,"start":749,"enrollment":750,"conditions":751,"interventions":753},"NCT06751875","Preventing Relapse After Successful Electroconvulsive Therapy for Depression",[55],"2024-12-01","2019-07-26",96,[752],"Major Depressive Disorder (MDD)",[730],{"intervention":755,"totalTrials":58,"cells":756},"COVID-19 vaccine",{"EARLY_PHASE1":757,"PHASE1":759,"PHASE2":761,"PHASE3":763,"PHASE4":765,"NA":767},{"trials":758,"activeCount":62},[],{"trials":760,"activeCount":62},[],{"trials":762,"activeCount":62},[],{"trials":764,"activeCount":62},[],{"trials":766,"activeCount":62},[],{"trials":768,"activeCount":62},[769],{"nctId":770,"briefTitle":771,"status":583,"phases":772,"primaryCompletion":773,"completion":774,"start":711,"enrollment":775,"conditions":776,"interventions":778},"NCT05618548","Vaccination Against COVID-19 in Pregnant and Lactating Women in Belgium",[],"2022-12-31","2023-06-30",110,[777],"Covid19",[755],{"intervention":780,"totalTrials":58,"cells":781},"Rosuvastatin-Crestor",{"EARLY_PHASE1":782,"PHASE1":784,"PHASE2":786,"PHASE3":788,"PHASE4":790,"NA":792},{"trials":783,"activeCount":62},[],{"trials":785,"activeCount":62},[],{"trials":787,"activeCount":62},[],{"trials":789,"activeCount":62},[],{"trials":791,"activeCount":62},[],{"trials":793,"activeCount":62},[794],{"nctId":795,"briefTitle":796,"status":159,"phases":797,"primaryCompletion":798,"completion":798,"start":799,"enrollment":9,"conditions":800,"interventions":802},"NCT00464503","Statins and the Urinary Proteome",[55],"2007-10","2007-09",[801],"Statin Induced Proteinuria",[780,803],"Pravastatin-Pravasine",{"intervention":803,"totalTrials":58,"cells":805},{"EARLY_PHASE1":806,"PHASE1":808,"PHASE2":810,"PHASE3":812,"PHASE4":814,"NA":816},{"trials":807,"activeCount":62},[],{"trials":809,"activeCount":62},[],{"trials":811,"activeCount":62},[],{"trials":813,"activeCount":62},[],{"trials":815,"activeCount":62},[],{"trials":817,"activeCount":62},[818],{"nctId":795,"briefTitle":796,"status":159,"phases":819,"primaryCompletion":798,"completion":798,"start":799,"enrollment":9,"conditions":820,"interventions":821},[55],[801],[780,803],{"intervention":823,"totalTrials":58,"cells":824},"Blood sampling",{"EARLY_PHASE1":825,"PHASE1":827,"PHASE2":829,"PHASE3":831,"PHASE4":833,"NA":835},{"trials":826,"activeCount":62},[],{"trials":828,"activeCount":62},[],{"trials":830,"activeCount":62},[],{"trials":832,"activeCount":62},[],{"trials":834,"activeCount":62},[],{"trials":836,"activeCount":62},[837],{"nctId":838,"briefTitle":839,"status":159,"phases":840,"primaryCompletion":841,"completion":841,"start":502,"enrollment":842,"conditions":843,"interventions":846},"NCT02009826","Psychosis-Associated Neuroinflammation in Schizophrenia",[],"2017-02",106,[844,845],"Schizophrenia","Psychosis",[823],{"intervention":848,"totalTrials":58,"cells":849},"Infant pertussis vaccination",{"EARLY_PHASE1":850,"PHASE1":852,"PHASE2":854,"PHASE3":856,"PHASE4":858,"NA":860},{"trials":851,"activeCount":62},[],{"trials":853,"activeCount":62},[],{"trials":855,"activeCount":62},[],{"trials":857,"activeCount":62},[],{"trials":859,"activeCount":62},[],{"trials":861,"activeCount":62},[862],{"nctId":863,"briefTitle":864,"status":583,"phases":865,"primaryCompletion":866,"start":867,"enrollment":868,"conditions":869,"interventions":870},"NCT02511327","Pertussis Immunization During Pregnancy: Effect in Term and Preterm Infants",[],"2019-01","2015-01",232,[166],[848],{"intervention":872,"totalTrials":58,"cells":873},"Macrolides",{"EARLY_PHASE1":874,"PHASE1":876,"PHASE2":878,"PHASE3":880,"PHASE4":882,"NA":884},{"trials":875,"activeCount":62},[],{"trials":877,"activeCount":62},[],{"trials":879,"activeCount":62},[],{"trials":881,"activeCount":62},[],{"trials":883,"activeCount":62},[],{"trials":885,"activeCount":62},[886],{"nctId":887,"briefTitle":888,"status":159,"phases":889,"completion":890,"start":891,"enrollment":892,"conditions":893,"interventions":895},"NCT00354952","Selection of Antibiotic Resistance by Azithromycin and Clarithromycin in the Oral Flora",[55],"2003-10","2002-07",203,[894],"Healthy Volunteers",[872]]